Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2014
05/15/2014WO2014039013A8 Tetrabranched peptides and analogues as a new class of antimicrobials and their preparation thereof
05/15/2014WO2014036562A3 Target peptides for immunotherapy and diagnostics
05/15/2014WO2013039956A3 Compositions and methods for treating mood disorders
05/15/2014WO2013036840A3 Peptide inhibitors of caspase 2 activation
05/15/2014WO2013036826A3 Streptavidin complexes and uses thereof
05/15/2014WO2013028615A3 Novel cyclosporin derivatives for the treatment and prevention of viral infections
05/15/2014WO2012174338A3 Method of selecting therapeutic indications
05/15/2014WO2012149440A3 Therapeutic nuclease compositions and methods
05/15/2014US20140135682 Super Fast-Acting Insulin Compositions
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
05/15/2014US20140135481 Humanized monoclonal antibodies that protect against shiga toxin induced disease
05/15/2014US20140135384 Endogenous retrovirus polypeptides linked to oncogenic transformation
05/15/2014US20140135383 Sdf-1 delivery for treating ischemic tissue
05/15/2014US20140135340 High Drug Load Tablet
05/15/2014US20140135273 Cb-183,314 compositions and related methods
05/15/2014US20140135271 Lamin A, An Activator of Longevity/Anti-Aging SIRT1 Protein
05/15/2014US20140135268 Surfactant protein d for the treatment of disorders associated with lung injury
05/15/2014US20140135266 Pharmaceutical composition for preventing or treating fibrosis
05/15/2014US20140135264 Compounds and methods of modulating angiogenesis
05/15/2014US20140135263 Rapid Acting Injectable Insulin Compositions
05/15/2014US20140135262 Lactoferrin and gut neuronal health in adults and/or elderly
05/15/2014US20140135261 Peptide yy and peptide yy agonists for treatment of metabolic disorders
05/15/2014US20140135260 Ghrelin Analogs
05/15/2014US20140135259 Treatment of hepatitis c virus
05/15/2014US20140135257 Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition
05/15/2014US20140135256 Treatment of extracellular matrix to reduce inflammation
05/15/2014US20140135254 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
05/15/2014US20140134722 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof
05/15/2014US20140134641 Masp-2, a complement fixing enzyme, and uses for it
05/15/2014US20140134276 Anti-tumor drug, medicament, composition, and use thereof
05/15/2014US20140134258 Implants for "load bearing" bone substitutions having hierarchical organized architecture deriving from transformation of vegetal structures
05/15/2014US20140134256 Drug Microparticles
05/15/2014US20140134250 Oxymorphone controlled release formulations
05/15/2014US20140134249 Biologic replacement for fibrin clot
05/15/2014US20140134237 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
05/15/2014US20140134233 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
05/15/2014US20140134231 Mir-211 expression and related pathways in human melanoma
05/15/2014US20140134225 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
05/15/2014US20140134213 Treatment of microbial infections
05/15/2014US20140134198 Epha2 t-cell epitope agonists and uses therefore
05/15/2014US20140134196 Vaccine and method for treatment of neurodegenerative diseases
05/15/2014US20140134188 Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof
05/15/2014US20140134182 Antibodies of the ed-b domain of fibronectin, their construction and uses
05/15/2014US20140134173 Composition and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
05/15/2014US20140134167 Transforming growth factor-beta (TGF-beta) antagonists for use in treating pain
05/15/2014US20140134157 Antibodies to opgl
05/15/2014US20140134152 Compositions and methods for treating diabetes
05/15/2014US20140134151 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
05/15/2014US20140134150 Technology for preparation of macromolecular microspheres
05/15/2014US20140134149 Enzymes for inhibiting growth of biofilms and degrading same
05/15/2014US20140134148 Brucella Abortus Proteins and Methods of Use Thereof
05/15/2014US20140134132 Cyclic peptides and use as medicines
05/15/2014US20140134129 RNA Vaccines
05/15/2014US20140134128 Multimeric il-15 soluble fusion molecules and methods of making and using same
05/15/2014US20140134106 Pharmaceutical composition of oxidised avidin suitable for inhalation
05/14/2014EP2730654A2 Neukinase, a downstream protein of neuregulin
05/14/2014EP2730604A2 Functionalized caprolactone monomers useful for making poly(ethylene oxide)-block-poly(ester) block copolymers
05/14/2014EP2730589A1 Peptide capable of promoting cell proliferation and use thereof
05/14/2014EP2730586A1 Protein-polypeptide complex with a specific activity on skin tissue, process for preparing same and pharmaceutical composition on the basis thereof
05/14/2014EP2730585A1 Protein-polypeptide complex with a specific effect on skin tissue, method for producing said complex and pharmaceutical composition on the basis thereof
05/14/2014EP2730584A1 Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof
05/14/2014EP2730581A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730580A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730579A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730288A1 Pharmaceutical composition for preventing or treating fibrosis
05/14/2014EP2730287A1 Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases
05/14/2014EP2729569A2 Multiple-enzyme nanocomplexes
05/14/2014EP2729495A1 Antagonist peptide of the bond between cd47 and a protein belonging to the thrombospondin family
05/14/2014EP2729485A1 Anti - amyloidogenic, alpha-helix breaking ultra-small peptide therapeutics
05/14/2014EP2729484A1 Cyclic tripeptide mimetics as plasmin inhibitors
05/14/2014EP2729483A1 Glutathione analogs and uses thereof
05/14/2014EP2729184A1 Novel agonists and antagonists of the urotensinergic system
05/14/2014EP2729179A1 Macromolecules
05/14/2014EP2729164A2 Formulations that stabilize proteins
05/14/2014EP2729163A1 Method for treatment of autonomic nervous system disorders
05/14/2014EP2729162A1 Method for treatment of esophageal spasm
05/14/2014EP2729161A2 Factor viii chimeric and hybrid polypeptides, and methods of use thereof
05/14/2014EP2729160A1 Engineered polypeptides having enhanced duration of action and reduced immunogenicity
05/14/2014EP2729159A2 Oral treatment of inflammatory bowel disease
05/14/2014EP2729158A1 Vaccines for chlamydia
05/14/2014EP2729157A2 Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1)
05/14/2014EP2729129A1 Formulations for wound therapy
05/14/2014CN203591506U 具有分解痰痂及消肿抗过敏功能的人工鼻 Sputum and swelling with exploded antiallergic function artificial nose
05/14/2014CN1985804B 谷胱甘肽传递系统 Glutathione delivery system
05/14/2014CN103797115A 具有快速加工性能的经过修饰的酸性α葡糖苷酶 Modified acid α-glucosidase with a rapid processing performance
05/14/2014CN103797025A 用精氨酸脱亚氨酶治疗的方法 Arginine deiminase treatment methods
05/14/2014CN103797024A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/14/2014CN103796684A 大分子 Macromolecules
05/14/2014CN103796672A 含有蛋白酶的药物组合物和治疗溶酶体贮积病的方法 Pharmaceutical compositions comprising a protease and a method for treating lysosomal storage disease
05/14/2014CN103796671A 促进β-β交联的制备含热稳定的氧载体的组合物的方法 Method for preparing β-β to promote crosslinking of the thermal stability of the oxygen-containing carrier composition
05/14/2014CN103796670A 因子viii嵌合和杂合多肽及其使用方法 Factor viii chimeric and hybrid polypeptides and methods of use
05/14/2014CN103796669A 治疗心血管疾病和预测运动疗法功效的方法 Treatment of cardiovascular disease and predict the efficacy of the method of exercise therapy
05/14/2014CN103796668A 含有血红蛋白的脂质体及其制造方法 Hemoglobin-containing liposomes and the manufacturing method
05/14/2014CN103796667A 用补体抑制剂治疗慢性障碍的方法 Methods complement inhibitor to treat chronic disorders
05/14/2014CN103796666A 改良的肽药物 Modified peptide drug
05/14/2014CN103796665A 芳香族阳离子肽及其用途 Aromatic-cationic peptides and their uses
05/14/2014CN103796664A 抗备解素抗体和其应用 Preparation of anti-hormone antibodies and their application Solution
05/14/2014CN103796534A 核苷酸用于改善水性微团酪蛋白组合物的热稳定性的用途 The use of nucleotides for the thermal stability improvement of the aqueous micellar casein composition
05/14/2014CN103789333A 一种口服重组融合蛋白tat-map30及制备方法和应用 An oral recombinant fusion protein tat-map30 and preparation method and application
05/14/2014CN103789317A 拟穴青蟹抗菌肽hyastatin基因克隆及编码蛋白重组和用途 Quasi points Scylla antimicrobial peptides and recombinant protein-coding gene cloning and use hyastatin
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 3163